These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2885419)
21. Asperlicin: a unique nonpeptide cholecystokinin antagonist. Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists). de Tullio P; Delarge J; Pirotte B Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792 [TBL] [Abstract][Full Text] [Related]
24. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring. Tranquillini ME; Cassarà PG; Corsi M; Curotto G; Donati D; Finizia G; Pentassuglia G; Polinelli S; Tarzia G; Ursini A; van Amsterdam FT Arch Pharm (Weinheim); 1997 Nov; 330(11):353-7. PubMed ID: 9431027 [No Abstract] [Full Text] [Related]
25. Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718. van der Bent A; Blommaert AG; Melman CT; IJzerman AP; van Wijngaarden I; Soudijn W J Med Chem; 1992 Mar; 35(6):1042-9. PubMed ID: 1552499 [TBL] [Abstract][Full Text] [Related]
26. Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists. Kerwin JF; Nadzan AM; Kopecka H; Lin CW; Miller T; Witte D; Burt S J Med Chem; 1989 Apr; 32(4):739-42. PubMed ID: 2704023 [No Abstract] [Full Text] [Related]
28. Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain. Sugaya K; Matsuda I; Kubota K Jpn J Pharmacol; 1987 Jan; 43(1):67-71. PubMed ID: 2883334 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists. Lattmann E; Billington DC; Poyner DR; Howitt SB; Offel M Drug Des Discov; 2001; 17(3):219-30. PubMed ID: 11469752 [TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors. Kerwin JF; Wagenaar F; Kopecka H; Lin CW; Miller T; Witte D; Stashko M; Nadzan AM J Med Chem; 1991 Dec; 34(12):3350-9. PubMed ID: 1766000 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696 [TBL] [Abstract][Full Text] [Related]
34. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists. Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363 [TBL] [Abstract][Full Text] [Related]
35. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119 [TBL] [Abstract][Full Text] [Related]
36. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors. Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053 [TBL] [Abstract][Full Text] [Related]
37. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1). Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632 [TBL] [Abstract][Full Text] [Related]